Back to Search Start Over

Febuxostat and its major acyl glucuronide metabolite are potent inhibitors of organic anion transporter 3: Implications for drug-drug interactions with rivaroxaban

Authors :
Lloyd Wei Tat Tang
Tino Woon Huai Cheong
Eric Chun Yong Chan
Source :
Biopharmaceuticsdrug dispositionREFERENCES. 43(2)
Publication Year :
2022

Abstract

Febuxostat is a second-line xanthine oxidase inhibitor that undergoes extensive hepatic metabolism to yield its major acyl-β-D-glucuronide metabolite (febuxostat AG). It was recently reported that febuxostat inhibited organic anion transporter 3 (OAT3)-mediated uptake of enalaprilat. Here, we investigated the inhibition of febuxostat and febuxostat AG on OAT3 in transfected human embryonic kidney 293 cells. Our transporter inhibition assays confirmed the potent noncompetitive and competitive inhibition of OAT3-mediated estrone-3-sulfate transport by febuxostat and febuxostat AG with corresponding apparent K

Details

ISSN :
1099081X
Volume :
43
Issue :
2
Database :
OpenAIRE
Journal :
Biopharmaceuticsdrug dispositionREFERENCES
Accession number :
edsair.doi.dedup.....3b10717eb52484eb9dd81bf8568da559